The growth of abdominal fat in chickens from broiler and layer-strains up to 10 weeks of age was measured and compared with changes in plasma very low density lipoprotein (VLDL) concentration and tissue lipoprotein lipase activities. The growth of abdominal fat in broilers was much more rapid than in layer-strain chickens. Plasma VLDL concentrations in the two strains were similar up to 5 weeks of age but thereafter concentrations tended to be higher in broilers. Plasma VLDL concentrations in both strains were much lower than those necessary for maximum lipoprotein lipase activity. The lipoprotein lipase activity of abdominal fat increased much more rapidly in broilers than in layer-strain chickens. In both strains the pattern of its increase relative to body weight was similar to that of abdominal fat. Differences in the lipoprotein lipase activity of abdominal fat between strains were attributed to differences in both activity/adipocyte and number of adipocytes. They were reduced or abolished if activity was expressed relative to tissue weight, or to its content of DNA or protein. The results strongly suggest that the greater lipoprotein lipase activity of the abdominal fat pad in broilers is an important factor in its rapid growth.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/00071668708416953 | DOI Listing |
AACE Clin Case Rep
August 2024
Department of Endocrinology, Endocrine Associates of West Village, New York City, New York.
Background/objective: Genetic causes of hypertriglyceridemia like familial chylomicronemia syndrome can be overlooked in everyday practice. We report a patient with a rare genetic mutation, highlighting the importance of genetic testing for timely diagnosis and prevention of complications.
Case Report: A 45-year-old Hispanic female presented with serum triglyceride levels of 749 mg/dL, refractory to rosuvastatin 10 mg daily and omega-3 ethyl esters 2 g daily.
Arch Dermatol Res
December 2024
Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, Shannxi, China.
Lipid metabolism disorders are frequently noted in atopic dermatitis (AD) patients, prompting the long-term use of lipid-lowering drugs. However, the causal effects of circulating lipids and different lipid-lowering drugs on the risk of AD are not thoroughly understood. Using publicly available genome-wide association studies (GWAS) summary data from two different cohorts, a series of Mendelian randomization (MR) analyses were conducted to explore the causal effects of genetically proxied circulating lipids and lipid-lowering drugs on the risk of AD.
View Article and Find Full Text PDFMedicine (Baltimore)
December 2024
National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Dyslipidemia has been established as a potential risk factor for venous thromboembolism (VTE) in several observational studies. Statins and novel lipid-modifying agents are being explored for their potential in VTE prevention, encompassing deep vein thrombosis (DVT), and pulmonary embolism (PE). Nonetheless, conclusive evidence supporting the effectiveness remains uncertain.
View Article and Find Full Text PDFPlacenta
December 2024
Department of Medical Biochemistry, Bozyaka Research and Training Hospital, Izmir, Turkey. Electronic address:
Introduction: Gestational diabetes mellitus (GDM) is defined as glucose intolerance during pregnancy. We aimed to investigate the potential effects of betatrophin and ApoC2 in GDM, focusing on their roles in LPL (lipoprotein lipase) regulation and their relationship with hPL to elucidate the possible impact of hPL on lipid metabolism and its potential contribution to the development of GDM.
Methods: Thirty pregnant women with normal glucose tolerance and 29 with gestational diabetes mellitus (diagnosed by 75g OGTT between 24 and 28 weeks) were included in the study.
QJM
December 2024
Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Hospital of China Medical University, Shenyang, P.R. China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!